0% commission for ETF trades
NASDAQ:ALKS
Alkermes plc Stock News
$28.35
+0.520 (+1.87%)
At Close: Sep 19, 2024
Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
07:00am, Friday, 13'th Sep 2024
— Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project — — Application Period to Run From Sept. 20, 2024 Through Nov. 30, 2024 — DUBLIN , Sept.
Here's Why Alkermes (ALKS) is a Strong Growth Stock
10:45am, Thursday, 05'th Sep 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Alkermes (ALKS) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 04'th Sep 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
04:00pm, Wednesday, 28'th Aug 2024
DUBLIN , Aug. 28, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat presentation at the Morgan Stanley 22nd Annual Global Healthcar
Alkermes (ALKS) Begins Narcolepsy Type 2 Study on ALKS 2680
12:15pm, Friday, 23'rd Aug 2024
Alkermes' (ALKS) phase II Vibrance-2 study investigates the safety and efficacy of ALKS 2680 versus placebo for treating adults with narcolepsy type 2.
Alkermes Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 2
07:00am, Thursday, 22'nd Aug 2024
DUBLIN , Aug. 22, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-2 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared
Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 20'th Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Alkermes (ALKS) is a Strong Value Stock
10:40am, Monday, 19'th Aug 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Alkermes (ALKS) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 16'th Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Alkermes (ALKS) is a Strong Growth Stock
10:45am, Thursday, 01'st Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Alkermes (ALKS) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 30'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alkermes' (ALKS) Q2 Earnings Miss Estimates, Revenues Beat
11:46am, Thursday, 25'th Jul 2024
Alkermes (ALKS) reports mixed second-quarter 2024 results. Earnings and revenues decline year over year.
Alkermes (ALKS) Reports Q2 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 24'th Jul 2024
The headline numbers for Alkermes (ALKS) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Alkermes (ALKS) Lags Q2 Earnings Estimates
09:15am, Wednesday, 24'th Jul 2024
Alkermes (ALKS) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.55 per share a year ago.
Alkermes plc Reports Second Quarter 2024 Financial Results
07:00am, Wednesday, 24'th Jul 2024
— Second Quarter Revenues of $399.1 Million — — Net Sales of Proprietary Products Increased Approximately 16% Year-Over-Year — — GAAP Net Income from Continuing Operations
